Nuclei scores $33M for AI-enabled pathology platform and more digital health fundings

The round was led by Section 32 and Sanofi Ventures, with participation from existing investors including Debiopharm, Fosun RZ Capital, Vertex Ventures and Grove Ventures. The startup said the latest round brings its total raise to nearly $50 million.